NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 0.8860
+0.0260 (3.02%)
Aug 21, 2026, 5:28 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €11.23 million as of August 21, 2026. Its market cap has decreased by -41.32% in one year.
Market Cap
11.23M
Enterprise Value
9.61M
Revenue
188.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.89
ChartMarket Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 11.23M, a decrease of -42.34%. That is a compound annual growth rate of -10.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 11.23M | -24.79% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 24.67M |
| Advicenne | 24.44M |
| genOway Société anonyme | 22.59M |
| Aelis Farma | 14.66M |
| Aton | 12.75M |
| Biophytis | 11.54M |
| Poxel | 10.54M |
| TME Pharma | 8.26M |